Katzenell Dimant /

KD represents HIL in series C financing


It has just been announced that Belgian company IBA (Ion Beam Applications S.A.), a provider of proton therapy solutions for the treatment of cancer, is leading a round of capital investment in our client HIL Applied Medical, Ltd. (HIL), a private Israeli developer of laser-based proton therapy systems.

Read the press on Globes here.



read more in: